SlideShare uma empresa Scribd logo
1 de 31
Baixar para ler offline
December 14, 2017
Getting to Approval
Faster through
Technology Innovation
© 2017 DIA, Inc. All rights reserved.
Speakers Bio
Page 2
Paul Slater
Director, and Worldwide Industry
Strategist, Pharmaceuticals
Educational Background:
• BSc (Hons) in Mathematics, King’s College London
Career Overview:
• Defines Microsoft’s strategy in life sciences,
including regulatory compliance approach for the
organization
• Author of multiple position papers on hybrid, private
and public cloud, platform modernization and IT
Portfolio Management
• Defined cloud and virtualization strategies across
multiple corporations
• @paul-slater
© 2017 DIA, Inc. All rights reserved.
Speakers Bio
Page 3
Matt Neal
Senior Director, Product Management –
Regulatory & Clinical Solutions
Educational Background:
• MA Communications, Temple University
Career Overview:
• Defines PAREXEL product strategy in Regulatory for
Life Sciences
• 20+ years in Industry (Amgen & GSK) Regulatory &
Safety Operations and electronic submissions pioneer
• Lifelong learner with a focus on disruptive innovation
and exponential technologies
• Knowledge Management expert and author
• Regulatory & Safety Operations Key Opinion Leader
• Frequent Conference Speaker andAuthor
• @matthewjneal
© 2017 DIA, Inc. All rights reserved. Page 4
Meredith Sewell
Executive Director, Allergan
Global Regulatory Affairs Submissions
Educational Background:
• BA, English Literature, University of California, Irvine
Career Overview:
• Defines Allergan’s Global Ops Submission Strategy and Process
• Drive Allergan’s partnership with Parexel to implement a cloud-
based, vendor-hosted RIM and Publishing system
• Reg Ops M&A integration and assimilation expert
(20+ companies in 2 years)
• Change management champion and optimizer of systems,
resources and processes
Describe factors that lead to inefficiencies in the
drug discovery and development process
Describe new technologies that will remove
those inefficiencies
Describe simplified powerful architectures
designed to enhance specialized regulatory
systems
Recognize how organizations will be simplified
as tools merge and become more intuitive
© 2017 DIA, Inc. All rights reserved.
Learning Objectives
Page 5
Introductions
Roundtable Discussion
Questions and answers
© 2017 DIA, Inc. All rights reserved.
Agenda
Page 6
© 2017 DIA, Inc. All rights reserved.
Question 1
Page 7
Why is time from
discovery to approval
going up?
Drug discovery is becoming slower and
more expensive over time, despite
improvements in technology (such as high
throughput screening, biotechnology,
combinatorial chemistry, and computational
drug design)
© 2017 DIA, Inc. All rights reserved.
Eroom’s Law
Page 8
© 2017 DIA, Inc. All rights reserved.
Where we are today
Page 9
Two years ago, Allergan became the
conglomeration of 4 large companies: Allergan,
Actavis, Watson, & Warner-Chilcott
Each had an Investigator Payment system
implemented and people to support them
Narrowed down to iMedidata, and IMPACT
iMedidata was not a “global” system but used
widely – large amt of trials + large team to
support
IMPACT also needed to sustain global trials
Sunshine Act requirements need to be met
© 2017 DIA, Inc. All rights reserved.
Allergan Investigator Payments - CTMS
Page 10
Technology and money are part of the problem
• Technology, people and process are entwined for both
Medidata and IMPACT
• Expert users and number of trials
• Expensive to integrate into one system
• Contracts, data migration, new training
• More expensive to retain two systems
• IT resources
• People + Process differences
• No central/single source of information
• Reporting and metrics are difficult
• New technology could bridge the gaps and create effective
opportunities for staff
© 2017 DIA, Inc. All rights reserved.
Allergan Investigator Payments (Cont’d)
Page 11
1999 – 2010s – Process of adding hyperlinks
was manual
Proper template use helped; rendered styles to
bookmarks, internal hyperlinks (cross-
references) retained
Touch up for bookmarks and hyperlinks were
produced with pdf plugin tools
Drawbacks: Time-consuming, people-driven,
last minute work
© 2017 DIA, Inc. All rights reserved.
Regulatory Submission Publishing – Evolution
of Bookmarking & Hyperlinking
Page 12
© 2017 DIA, Inc. All rights reserved.
Question 2
Page 13
Can we reverse the
trend?
© 2017 DIA, Inc. All rights reserved.
Where we are today
Page 14
© 2017 DIA, Inc. All rights reserved.
What is needed
Page 15
Applications
Data
Self-improving productsFlexible Architectures
As Is
To Be
© 2017 DIA, Inc. All rights reserved.
Question 3
Page 16
What do flexible
architectures look like?
© 2017 DIA, Inc. All rights reserved.
POLL
Page 17
Where are you in your cloud journey?
 Fully on-premise (no cloud)
 Dev/Test in the cloud
 At least one Prod environment in the cloud
 All environments in the cloud
© 2017 DIA, Inc. All rights reserved.
POLL
Page 18
What is your biggest concern in adopting cloud
computing?
 Maintaining Security
 Maintaining Data Integrity
 Loss of Control
 Disaster Recovery
 Regulatory Compliance
New view of Line of Business Architectures
Data Architecture for Life Sciences
Flexibility from Cloud Based Architectures
Old World New World
IT department has to plan upgrades
Flexibility from Cloud Based Architectures
Old World New World
IT department has to plan upgrades No more upgrades, new features roll
into product on an agreed schedule
Flexibility from Cloud Based Architectures
Old World New World
IT department has to plan upgrades No more upgrades, new features roll
into product on an agreed schedule
High maintenance costs to maintain
and integrate the platform
Flexibility from Cloud Based Architectures
Old World New World
IT department has to plan upgrades No more upgrades, new features roll
into product on an agreed schedule
High maintenance costs to maintain
and integrate the platform
Maintenance built into the architecture.
Simplified data integration through
common data architecture
Flexibility from Cloud Based Architectures
Old World New World
IT department has to plan upgrades No more upgrades, new features roll
into product on an agreed schedule
High maintenance costs to maintain
and integrate the platform
Maintenance built into the architecture.
Simplified data integration through
common data architecture
“Feature drop” to meet version
deadlines
Flexibility from Cloud Based Architectures
Old World New World
IT department has to plan upgrades No more upgrades, new features roll
into product on an agreed schedule
High maintenance costs to maintain
and integrate the platform
Maintenance built into the architecture.
Simplified data integration through
common data architecture
“Feature drop” to meet version
deadlines
Features developed according to
customer demand, and rolled into
product according to agreed schedule
Flexibility from Cloud Based Architectures
Old World New World
IT department has to plan upgrades No more upgrades, new features roll
into product on an agreed schedule
High maintenance costs to maintain
and integrate the platform
Maintenance built into the architecture.
Simplified data integration through
common data architecture
“Feature drop” to meet version
deadlines
Features developed according to
customer demand, and rolled into
product according to agreed schedule
No benefit to adding new products and
services
Flexibility from Cloud Based Architectures
Old World New World
IT department has to plan upgrades No more upgrades, new features roll
into product on an agreed schedule
High maintenance costs to maintain
and integrate the platform
Maintenance built into the architecture.
Simplified data integration through
common data architecture
“Feature drop” to meet version
deadlines
Features developed according to
customer demand, and rolled into
product according to agreed schedule
No benefit to adding new products and
services
Data insights enhanced as new
services are added
Vivli – Data Sharing Platform
29
CORE STRATEGY
DIGITAL TRANSFORMATION – SOLUTIONCONVERGENCE
Getting to Approval Faster Through Technology Innovation

Mais conteúdo relacionado

Mais procurados

Lamarche Models And Outcomes
Lamarche Models And OutcomesLamarche Models And Outcomes
Lamarche Models And Outcomesprimary
 
Opportunities and Challenges Associated with Novel Companion Diagnostic Techn...
Opportunities and Challenges Associated with Novel Companion Diagnostic Techn...Opportunities and Challenges Associated with Novel Companion Diagnostic Techn...
Opportunities and Challenges Associated with Novel Companion Diagnostic Techn...L.E.K. Consulting
 
ScienceCloud: Collaborative Workflows in Biologics R&D
ScienceCloud: Collaborative Workflows in Biologics R&DScienceCloud: Collaborative Workflows in Biologics R&D
ScienceCloud: Collaborative Workflows in Biologics R&DBIOVIA
 
Transforming Pharmacovigilance Workflows with AI & Automation
Transforming Pharmacovigilance Workflows with AI & Automation Transforming Pharmacovigilance Workflows with AI & Automation
Transforming Pharmacovigilance Workflows with AI & Automation Perficient, Inc.
 
Late Binding: The New Standard For Data Warehousing
Late Binding: The New Standard For Data WarehousingLate Binding: The New Standard For Data Warehousing
Late Binding: The New Standard For Data WarehousingHealth Catalyst
 
Combining Patient Records, Genomic Data and Environmental Data to Enable Tran...
Combining Patient Records, Genomic Data and Environmental Data to Enable Tran...Combining Patient Records, Genomic Data and Environmental Data to Enable Tran...
Combining Patient Records, Genomic Data and Environmental Data to Enable Tran...Perficient, Inc.
 
Pistoia alliance debates analytics 15-09-2015 16.00
Pistoia alliance debates   analytics 15-09-2015 16.00Pistoia alliance debates   analytics 15-09-2015 16.00
Pistoia alliance debates analytics 15-09-2015 16.00Pistoia Alliance
 
Placebo and Standard of Care Data Sharing Initiative - PSoC Data Sharing
Placebo and Standard of Care Data Sharing Initiative - PSoC Data SharingPlacebo and Standard of Care Data Sharing Initiative - PSoC Data Sharing
Placebo and Standard of Care Data Sharing Initiative - PSoC Data SharingTransCelerate
 
Medisafe_What's Next in RWE_mHealth Israel
Medisafe_What's Next in RWE_mHealth IsraelMedisafe_What's Next in RWE_mHealth Israel
Medisafe_What's Next in RWE_mHealth IsraelLevi Shapiro
 
United Health Group Entire Annual Report (1360k)
United Health Group Entire Annual Report (1360k)United Health Group Entire Annual Report (1360k)
United Health Group Entire Annual Report (1360k)finance3
 
Duality Technologies_Driving Secure Collaboration in Healthcare_mHealth Israel
Duality Technologies_Driving Secure Collaboration in Healthcare_mHealth IsraelDuality Technologies_Driving Secure Collaboration in Healthcare_mHealth Israel
Duality Technologies_Driving Secure Collaboration in Healthcare_mHealth IsraelLevi Shapiro
 
2005 2016 connect-springboard_impact_report_digital
2005 2016 connect-springboard_impact_report_digital2005 2016 connect-springboard_impact_report_digital
2005 2016 connect-springboard_impact_report_digitalBioPharma Strategy Advisors
 
Effective Late Stage Pathways for Biosimilar Products
Effective Late Stage Pathways for Biosimilar ProductsEffective Late Stage Pathways for Biosimilar Products
Effective Late Stage Pathways for Biosimilar ProductsPAREXEL International
 
mHealth Israel_Growth Opportunities in Clinical Trial Execution_Craig Lipset
mHealth Israel_Growth Opportunities in Clinical Trial Execution_Craig LipsetmHealth Israel_Growth Opportunities in Clinical Trial Execution_Craig Lipset
mHealth Israel_Growth Opportunities in Clinical Trial Execution_Craig LipsetLevi Shapiro
 
UCSF Informatics Day 2014 - David Dobbs, "Enterprise Data Warehouse"
UCSF Informatics Day 2014 - David Dobbs, "Enterprise Data Warehouse"UCSF Informatics Day 2014 - David Dobbs, "Enterprise Data Warehouse"
UCSF Informatics Day 2014 - David Dobbs, "Enterprise Data Warehouse"CTSI at UCSF
 
TransCelerate Overview - Value of Safety Information Data Sources Initiative
TransCelerate Overview - Value of Safety Information Data Sources InitiativeTransCelerate Overview - Value of Safety Information Data Sources Initiative
TransCelerate Overview - Value of Safety Information Data Sources InitiativeTransCelerate
 
ValGenesis Case Study With Scinopharm -Paperless Validation Software Solution
ValGenesis Case Study With Scinopharm -Paperless Validation Software Solution ValGenesis Case Study With Scinopharm -Paperless Validation Software Solution
ValGenesis Case Study With Scinopharm -Paperless Validation Software Solution ValGenesis
 
Healthcare Information Analytics
Healthcare Information AnalyticsHealthcare Information Analytics
Healthcare Information AnalyticsFrank Wang
 
For Life Sciences, the Future of Master Data Management is in the Cloud
For Life Sciences, the Future of Master Data Management is in the CloudFor Life Sciences, the Future of Master Data Management is in the Cloud
For Life Sciences, the Future of Master Data Management is in the CloudCognizant
 

Mais procurados (20)

Lamarche Models And Outcomes
Lamarche Models And OutcomesLamarche Models And Outcomes
Lamarche Models And Outcomes
 
Opportunities and Challenges Associated with Novel Companion Diagnostic Techn...
Opportunities and Challenges Associated with Novel Companion Diagnostic Techn...Opportunities and Challenges Associated with Novel Companion Diagnostic Techn...
Opportunities and Challenges Associated with Novel Companion Diagnostic Techn...
 
ScienceCloud: Collaborative Workflows in Biologics R&D
ScienceCloud: Collaborative Workflows in Biologics R&DScienceCloud: Collaborative Workflows in Biologics R&D
ScienceCloud: Collaborative Workflows in Biologics R&D
 
Transforming Pharmacovigilance Workflows with AI & Automation
Transforming Pharmacovigilance Workflows with AI & Automation Transforming Pharmacovigilance Workflows with AI & Automation
Transforming Pharmacovigilance Workflows with AI & Automation
 
Late Binding: The New Standard For Data Warehousing
Late Binding: The New Standard For Data WarehousingLate Binding: The New Standard For Data Warehousing
Late Binding: The New Standard For Data Warehousing
 
Combining Patient Records, Genomic Data and Environmental Data to Enable Tran...
Combining Patient Records, Genomic Data and Environmental Data to Enable Tran...Combining Patient Records, Genomic Data and Environmental Data to Enable Tran...
Combining Patient Records, Genomic Data and Environmental Data to Enable Tran...
 
Pistoia alliance debates analytics 15-09-2015 16.00
Pistoia alliance debates   analytics 15-09-2015 16.00Pistoia alliance debates   analytics 15-09-2015 16.00
Pistoia alliance debates analytics 15-09-2015 16.00
 
Placebo and Standard of Care Data Sharing Initiative - PSoC Data Sharing
Placebo and Standard of Care Data Sharing Initiative - PSoC Data SharingPlacebo and Standard of Care Data Sharing Initiative - PSoC Data Sharing
Placebo and Standard of Care Data Sharing Initiative - PSoC Data Sharing
 
Medisafe_What's Next in RWE_mHealth Israel
Medisafe_What's Next in RWE_mHealth IsraelMedisafe_What's Next in RWE_mHealth Israel
Medisafe_What's Next in RWE_mHealth Israel
 
United Health Group Entire Annual Report (1360k)
United Health Group Entire Annual Report (1360k)United Health Group Entire Annual Report (1360k)
United Health Group Entire Annual Report (1360k)
 
Duality Technologies_Driving Secure Collaboration in Healthcare_mHealth Israel
Duality Technologies_Driving Secure Collaboration in Healthcare_mHealth IsraelDuality Technologies_Driving Secure Collaboration in Healthcare_mHealth Israel
Duality Technologies_Driving Secure Collaboration in Healthcare_mHealth Israel
 
2005 2016 connect-springboard_impact_report_digital
2005 2016 connect-springboard_impact_report_digital2005 2016 connect-springboard_impact_report_digital
2005 2016 connect-springboard_impact_report_digital
 
Effective Late Stage Pathways for Biosimilar Products
Effective Late Stage Pathways for Biosimilar ProductsEffective Late Stage Pathways for Biosimilar Products
Effective Late Stage Pathways for Biosimilar Products
 
mHealth Israel_Growth Opportunities in Clinical Trial Execution_Craig Lipset
mHealth Israel_Growth Opportunities in Clinical Trial Execution_Craig LipsetmHealth Israel_Growth Opportunities in Clinical Trial Execution_Craig Lipset
mHealth Israel_Growth Opportunities in Clinical Trial Execution_Craig Lipset
 
my publication
my publicationmy publication
my publication
 
UCSF Informatics Day 2014 - David Dobbs, "Enterprise Data Warehouse"
UCSF Informatics Day 2014 - David Dobbs, "Enterprise Data Warehouse"UCSF Informatics Day 2014 - David Dobbs, "Enterprise Data Warehouse"
UCSF Informatics Day 2014 - David Dobbs, "Enterprise Data Warehouse"
 
TransCelerate Overview - Value of Safety Information Data Sources Initiative
TransCelerate Overview - Value of Safety Information Data Sources InitiativeTransCelerate Overview - Value of Safety Information Data Sources Initiative
TransCelerate Overview - Value of Safety Information Data Sources Initiative
 
ValGenesis Case Study With Scinopharm -Paperless Validation Software Solution
ValGenesis Case Study With Scinopharm -Paperless Validation Software Solution ValGenesis Case Study With Scinopharm -Paperless Validation Software Solution
ValGenesis Case Study With Scinopharm -Paperless Validation Software Solution
 
Healthcare Information Analytics
Healthcare Information AnalyticsHealthcare Information Analytics
Healthcare Information Analytics
 
For Life Sciences, the Future of Master Data Management is in the Cloud
For Life Sciences, the Future of Master Data Management is in the CloudFor Life Sciences, the Future of Master Data Management is in the Cloud
For Life Sciences, the Future of Master Data Management is in the Cloud
 

Semelhante a Getting to Approval Faster Through Technology Innovation

Big Data LDN 2017: The New Dominant Companies Are Running on Data
Big Data LDN 2017: The New Dominant Companies Are Running on DataBig Data LDN 2017: The New Dominant Companies Are Running on Data
Big Data LDN 2017: The New Dominant Companies Are Running on DataMatt Stubbs
 
Big Data LDN 2017: The New Dominant Companies Are Running on Data
Big Data LDN 2017: The New Dominant Companies Are Running on DataBig Data LDN 2017: The New Dominant Companies Are Running on Data
Big Data LDN 2017: The New Dominant Companies Are Running on DataMatt Stubbs
 
The new dominant companies are running on data
The new dominant companies are running on data The new dominant companies are running on data
The new dominant companies are running on data SnapLogic
 
Session T2 - Best Practice Project Controls with EcoSys
Session T2 - Best Practice Project Controls with EcoSysSession T2 - Best Practice Project Controls with EcoSys
Session T2 - Best Practice Project Controls with EcoSysProject Controls Expo
 
Capgemini Leap Data Transformation Framework with Cloudera
Capgemini Leap Data Transformation Framework with ClouderaCapgemini Leap Data Transformation Framework with Cloudera
Capgemini Leap Data Transformation Framework with ClouderaCapgemini
 
Implementar una estrategia eficiente de gobierno y seguridad del dato con la ...
Implementar una estrategia eficiente de gobierno y seguridad del dato con la ...Implementar una estrategia eficiente de gobierno y seguridad del dato con la ...
Implementar una estrategia eficiente de gobierno y seguridad del dato con la ...Denodo
 
¿En qué se parece el Gobierno del Dato a un parque de atracciones?
¿En qué se parece el Gobierno del Dato a un parque de atracciones?¿En qué se parece el Gobierno del Dato a un parque de atracciones?
¿En qué se parece el Gobierno del Dato a un parque de atracciones?Denodo
 
Insights into Real-world Data Management Challenges
Insights into Real-world Data Management ChallengesInsights into Real-world Data Management Challenges
Insights into Real-world Data Management ChallengesDataWorks Summit
 
Postgres Vision 2018: Making Modern an Old Legacy System
Postgres Vision 2018: Making Modern an Old Legacy SystemPostgres Vision 2018: Making Modern an Old Legacy System
Postgres Vision 2018: Making Modern an Old Legacy SystemEDB
 
Solving the Data Management Challenge for Healthcare
Solving the Data Management Challenge for HealthcareSolving the Data Management Challenge for Healthcare
Solving the Data Management Challenge for HealthcareDelphix
 
Elastic's recommendation on keeping services up and running with real-time vi...
Elastic's recommendation on keeping services up and running with real-time vi...Elastic's recommendation on keeping services up and running with real-time vi...
Elastic's recommendation on keeping services up and running with real-time vi...FaithWestdorp
 
Modernizing IT in the Platform Era
Modernizing IT in the Platform EraModernizing IT in the Platform Era
Modernizing IT in the Platform EraApcera
 
The Five Markers on Your Big Data Journey
The Five Markers on Your Big Data JourneyThe Five Markers on Your Big Data Journey
The Five Markers on Your Big Data JourneyCloudera, Inc.
 
AWS May Webinar Series - Industry Trends and Best Practices for Cloud Adoption
AWS May Webinar Series - Industry Trends and Best Practices for Cloud AdoptionAWS May Webinar Series - Industry Trends and Best Practices for Cloud Adoption
AWS May Webinar Series - Industry Trends and Best Practices for Cloud AdoptionAmazon Web Services
 
Insights into Real World Data Management Challenges
Insights into Real World Data Management ChallengesInsights into Real World Data Management Challenges
Insights into Real World Data Management ChallengesDataWorks Summit
 
Bt idc event cloud adoption in ireland
Bt  idc event cloud adoption in irelandBt  idc event cloud adoption in ireland
Bt idc event cloud adoption in irelandFiona Sexton
 
Linked data the next 5 years - From Hype to Action
Linked data the next 5 years - From Hype to ActionLinked data the next 5 years - From Hype to Action
Linked data the next 5 years - From Hype to ActionAndreas Blumauer
 
Big Data in Oil and Gas: How to Tap Its Full Potential
Big Data in Oil and Gas: How to Tap Its Full PotentialBig Data in Oil and Gas: How to Tap Its Full Potential
Big Data in Oil and Gas: How to Tap Its Full PotentialHitachi Vantara
 
Accelerating Innovation in Energy
Accelerating Innovation in EnergyAccelerating Innovation in Energy
Accelerating Innovation in Energyaccenture
 
How to add security in dataops and devops
How to add security in dataops and devopsHow to add security in dataops and devops
How to add security in dataops and devopsUlf Mattsson
 

Semelhante a Getting to Approval Faster Through Technology Innovation (20)

Big Data LDN 2017: The New Dominant Companies Are Running on Data
Big Data LDN 2017: The New Dominant Companies Are Running on DataBig Data LDN 2017: The New Dominant Companies Are Running on Data
Big Data LDN 2017: The New Dominant Companies Are Running on Data
 
Big Data LDN 2017: The New Dominant Companies Are Running on Data
Big Data LDN 2017: The New Dominant Companies Are Running on DataBig Data LDN 2017: The New Dominant Companies Are Running on Data
Big Data LDN 2017: The New Dominant Companies Are Running on Data
 
The new dominant companies are running on data
The new dominant companies are running on data The new dominant companies are running on data
The new dominant companies are running on data
 
Session T2 - Best Practice Project Controls with EcoSys
Session T2 - Best Practice Project Controls with EcoSysSession T2 - Best Practice Project Controls with EcoSys
Session T2 - Best Practice Project Controls with EcoSys
 
Capgemini Leap Data Transformation Framework with Cloudera
Capgemini Leap Data Transformation Framework with ClouderaCapgemini Leap Data Transformation Framework with Cloudera
Capgemini Leap Data Transformation Framework with Cloudera
 
Implementar una estrategia eficiente de gobierno y seguridad del dato con la ...
Implementar una estrategia eficiente de gobierno y seguridad del dato con la ...Implementar una estrategia eficiente de gobierno y seguridad del dato con la ...
Implementar una estrategia eficiente de gobierno y seguridad del dato con la ...
 
¿En qué se parece el Gobierno del Dato a un parque de atracciones?
¿En qué se parece el Gobierno del Dato a un parque de atracciones?¿En qué se parece el Gobierno del Dato a un parque de atracciones?
¿En qué se parece el Gobierno del Dato a un parque de atracciones?
 
Insights into Real-world Data Management Challenges
Insights into Real-world Data Management ChallengesInsights into Real-world Data Management Challenges
Insights into Real-world Data Management Challenges
 
Postgres Vision 2018: Making Modern an Old Legacy System
Postgres Vision 2018: Making Modern an Old Legacy SystemPostgres Vision 2018: Making Modern an Old Legacy System
Postgres Vision 2018: Making Modern an Old Legacy System
 
Solving the Data Management Challenge for Healthcare
Solving the Data Management Challenge for HealthcareSolving the Data Management Challenge for Healthcare
Solving the Data Management Challenge for Healthcare
 
Elastic's recommendation on keeping services up and running with real-time vi...
Elastic's recommendation on keeping services up and running with real-time vi...Elastic's recommendation on keeping services up and running with real-time vi...
Elastic's recommendation on keeping services up and running with real-time vi...
 
Modernizing IT in the Platform Era
Modernizing IT in the Platform EraModernizing IT in the Platform Era
Modernizing IT in the Platform Era
 
The Five Markers on Your Big Data Journey
The Five Markers on Your Big Data JourneyThe Five Markers on Your Big Data Journey
The Five Markers on Your Big Data Journey
 
AWS May Webinar Series - Industry Trends and Best Practices for Cloud Adoption
AWS May Webinar Series - Industry Trends and Best Practices for Cloud AdoptionAWS May Webinar Series - Industry Trends and Best Practices for Cloud Adoption
AWS May Webinar Series - Industry Trends and Best Practices for Cloud Adoption
 
Insights into Real World Data Management Challenges
Insights into Real World Data Management ChallengesInsights into Real World Data Management Challenges
Insights into Real World Data Management Challenges
 
Bt idc event cloud adoption in ireland
Bt  idc event cloud adoption in irelandBt  idc event cloud adoption in ireland
Bt idc event cloud adoption in ireland
 
Linked data the next 5 years - From Hype to Action
Linked data the next 5 years - From Hype to ActionLinked data the next 5 years - From Hype to Action
Linked data the next 5 years - From Hype to Action
 
Big Data in Oil and Gas: How to Tap Its Full Potential
Big Data in Oil and Gas: How to Tap Its Full PotentialBig Data in Oil and Gas: How to Tap Its Full Potential
Big Data in Oil and Gas: How to Tap Its Full Potential
 
Accelerating Innovation in Energy
Accelerating Innovation in EnergyAccelerating Innovation in Energy
Accelerating Innovation in Energy
 
How to add security in dataops and devops
How to add security in dataops and devopsHow to add security in dataops and devops
How to add security in dataops and devops
 

Mais de PAREXEL International

Improving Processes for Temperature Traceability from Packaging to Patient
Improving Processes for Temperature Traceability from Packaging to PatientImproving Processes for Temperature Traceability from Packaging to Patient
Improving Processes for Temperature Traceability from Packaging to PatientPAREXEL International
 
Effective Strategies for Successful Global Development
Effective Strategies for Successful Global DevelopmentEffective Strategies for Successful Global Development
Effective Strategies for Successful Global DevelopmentPAREXEL International
 
Understanding Regulatory and Payer Requirements Throughout Commercialization
Understanding Regulatory and Payer Requirements Throughout CommercializationUnderstanding Regulatory and Payer Requirements Throughout Commercialization
Understanding Regulatory and Payer Requirements Throughout CommercializationPAREXEL International
 
Innovative Pricing and Reimbursement Schemes - The Why, What, Which & How
Innovative Pricing and Reimbursement Schemes - The Why, What, Which & HowInnovative Pricing and Reimbursement Schemes - The Why, What, Which & How
Innovative Pricing and Reimbursement Schemes - The Why, What, Which & HowPAREXEL International
 
Leveraging Imaging and Wearable Technology For Agile Clinical Trials
Leveraging Imaging and Wearable Technology For Agile Clinical TrialsLeveraging Imaging and Wearable Technology For Agile Clinical Trials
Leveraging Imaging and Wearable Technology For Agile Clinical TrialsPAREXEL International
 
Effective Regulatory Strategies for China Market Entry
Effective Regulatory Strategies for China Market EntryEffective Regulatory Strategies for China Market Entry
Effective Regulatory Strategies for China Market EntryPAREXEL International
 
Seamless Dataflow with a Clinical Metadata Repository
Seamless Dataflow with a Clinical Metadata RepositorySeamless Dataflow with a Clinical Metadata Repository
Seamless Dataflow with a Clinical Metadata RepositoryPAREXEL International
 
FDA Initiatives Under The 21st Century Cures Act
FDA Initiatives Under The 21st Century Cures ActFDA Initiatives Under The 21st Century Cures Act
FDA Initiatives Under The 21st Century Cures ActPAREXEL International
 
Exploring Ways to Enhance Evidence Generation & Communication Planning
Exploring Ways to Enhance Evidence Generation & Communication PlanningExploring Ways to Enhance Evidence Generation & Communication Planning
Exploring Ways to Enhance Evidence Generation & Communication PlanningPAREXEL International
 
Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpo...
Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpo...Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpo...
Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpo...PAREXEL International
 
Development Considerations Comparing Major Markets Including US, EU, Japan an...
Development Considerations Comparing Major Markets Including US, EU, Japan an...Development Considerations Comparing Major Markets Including US, EU, Japan an...
Development Considerations Comparing Major Markets Including US, EU, Japan an...PAREXEL International
 
Understanding Different Stakeholder Requirements Throughout Commercialization
Understanding Different Stakeholder Requirements Throughout CommercializationUnderstanding Different Stakeholder Requirements Throughout Commercialization
Understanding Different Stakeholder Requirements Throughout CommercializationPAREXEL International
 
The Art and Science of Productive FDA Meetings
The Art and Science of Productive FDA MeetingsThe Art and Science of Productive FDA Meetings
The Art and Science of Productive FDA MeetingsPAREXEL International
 
Generating Evidence to Drive Patient Access
Generating Evidence to Drive Patient AccessGenerating Evidence to Drive Patient Access
Generating Evidence to Drive Patient AccessPAREXEL International
 
Regulatory Strategy In Emerging Markets
Regulatory Strategy In Emerging MarketsRegulatory Strategy In Emerging Markets
Regulatory Strategy In Emerging MarketsPAREXEL International
 
Aligning on Patient Outcomes - How Market Dynamics Can Facilitate RWD Solutions
Aligning on Patient Outcomes - How Market Dynamics Can Facilitate RWD SolutionsAligning on Patient Outcomes - How Market Dynamics Can Facilitate RWD Solutions
Aligning on Patient Outcomes - How Market Dynamics Can Facilitate RWD SolutionsPAREXEL International
 
You're Hot Then You're Cold - Temperature Management & RTSM Integration
You're Hot Then You're Cold - Temperature Management & RTSM IntegrationYou're Hot Then You're Cold - Temperature Management & RTSM Integration
You're Hot Then You're Cold - Temperature Management & RTSM IntegrationPAREXEL International
 

Mais de PAREXEL International (20)

Improving Processes for Temperature Traceability from Packaging to Patient
Improving Processes for Temperature Traceability from Packaging to PatientImproving Processes for Temperature Traceability from Packaging to Patient
Improving Processes for Temperature Traceability from Packaging to Patient
 
Life of a Biosimilar
Life of a BiosimilarLife of a Biosimilar
Life of a Biosimilar
 
Effective Strategies for Successful Global Development
Effective Strategies for Successful Global DevelopmentEffective Strategies for Successful Global Development
Effective Strategies for Successful Global Development
 
Trends in Early Development
Trends in Early DevelopmentTrends in Early Development
Trends in Early Development
 
Understanding Regulatory and Payer Requirements Throughout Commercialization
Understanding Regulatory and Payer Requirements Throughout CommercializationUnderstanding Regulatory and Payer Requirements Throughout Commercialization
Understanding Regulatory and Payer Requirements Throughout Commercialization
 
Innovative Pricing and Reimbursement Schemes - The Why, What, Which & How
Innovative Pricing and Reimbursement Schemes - The Why, What, Which & HowInnovative Pricing and Reimbursement Schemes - The Why, What, Which & How
Innovative Pricing and Reimbursement Schemes - The Why, What, Which & How
 
Leveraging Imaging and Wearable Technology For Agile Clinical Trials
Leveraging Imaging and Wearable Technology For Agile Clinical TrialsLeveraging Imaging and Wearable Technology For Agile Clinical Trials
Leveraging Imaging and Wearable Technology For Agile Clinical Trials
 
Effective Regulatory Strategies for China Market Entry
Effective Regulatory Strategies for China Market EntryEffective Regulatory Strategies for China Market Entry
Effective Regulatory Strategies for China Market Entry
 
Seamless Dataflow with a Clinical Metadata Repository
Seamless Dataflow with a Clinical Metadata RepositorySeamless Dataflow with a Clinical Metadata Repository
Seamless Dataflow with a Clinical Metadata Repository
 
FDA Initiatives Under The 21st Century Cures Act
FDA Initiatives Under The 21st Century Cures ActFDA Initiatives Under The 21st Century Cures Act
FDA Initiatives Under The 21st Century Cures Act
 
Exploring Ways to Enhance Evidence Generation & Communication Planning
Exploring Ways to Enhance Evidence Generation & Communication PlanningExploring Ways to Enhance Evidence Generation & Communication Planning
Exploring Ways to Enhance Evidence Generation & Communication Planning
 
Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpo...
Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpo...Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpo...
Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpo...
 
Development Considerations Comparing Major Markets Including US, EU, Japan an...
Development Considerations Comparing Major Markets Including US, EU, Japan an...Development Considerations Comparing Major Markets Including US, EU, Japan an...
Development Considerations Comparing Major Markets Including US, EU, Japan an...
 
Understanding Different Stakeholder Requirements Throughout Commercialization
Understanding Different Stakeholder Requirements Throughout CommercializationUnderstanding Different Stakeholder Requirements Throughout Commercialization
Understanding Different Stakeholder Requirements Throughout Commercialization
 
RIM & IDMP Synergies
RIM & IDMP SynergiesRIM & IDMP Synergies
RIM & IDMP Synergies
 
The Art and Science of Productive FDA Meetings
The Art and Science of Productive FDA MeetingsThe Art and Science of Productive FDA Meetings
The Art and Science of Productive FDA Meetings
 
Generating Evidence to Drive Patient Access
Generating Evidence to Drive Patient AccessGenerating Evidence to Drive Patient Access
Generating Evidence to Drive Patient Access
 
Regulatory Strategy In Emerging Markets
Regulatory Strategy In Emerging MarketsRegulatory Strategy In Emerging Markets
Regulatory Strategy In Emerging Markets
 
Aligning on Patient Outcomes - How Market Dynamics Can Facilitate RWD Solutions
Aligning on Patient Outcomes - How Market Dynamics Can Facilitate RWD SolutionsAligning on Patient Outcomes - How Market Dynamics Can Facilitate RWD Solutions
Aligning on Patient Outcomes - How Market Dynamics Can Facilitate RWD Solutions
 
You're Hot Then You're Cold - Temperature Management & RTSM Integration
You're Hot Then You're Cold - Temperature Management & RTSM IntegrationYou're Hot Then You're Cold - Temperature Management & RTSM Integration
You're Hot Then You're Cold - Temperature Management & RTSM Integration
 

Último

Organizational Transformation Lead with Culture
Organizational Transformation Lead with CultureOrganizational Transformation Lead with Culture
Organizational Transformation Lead with CultureSeta Wicaksana
 
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai KuwaitThe Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwaitdaisycvs
 
CROSS CULTURAL NEGOTIATION BY PANMISEM NS
CROSS CULTURAL NEGOTIATION BY PANMISEM NSCROSS CULTURAL NEGOTIATION BY PANMISEM NS
CROSS CULTURAL NEGOTIATION BY PANMISEM NSpanmisemningshen123
 
BeMetals Investor Presentation_May 3, 2024.pdf
BeMetals Investor Presentation_May 3, 2024.pdfBeMetals Investor Presentation_May 3, 2024.pdf
BeMetals Investor Presentation_May 3, 2024.pdfDerekIwanaka1
 
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in OmanMifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Omaninstagramfab782445
 
Falcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investorsFalcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investorsFalcon Invoice Discounting
 
Falcon Invoice Discounting: Tailored Financial Wings
Falcon Invoice Discounting: Tailored Financial WingsFalcon Invoice Discounting: Tailored Financial Wings
Falcon Invoice Discounting: Tailored Financial WingsFalcon Invoice Discounting
 
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAIGetting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAITim Wilson
 
Katrina Personal Brand Project and portfolio 1
Katrina Personal Brand Project and portfolio 1Katrina Personal Brand Project and portfolio 1
Katrina Personal Brand Project and portfolio 1kcpayne
 
Famous Olympic Siblings from the 21st Century
Famous Olympic Siblings from the 21st CenturyFamous Olympic Siblings from the 21st Century
Famous Olympic Siblings from the 21st Centuryrwgiffor
 
Cracking the 'Career Pathing' Slideshare
Cracking the 'Career Pathing' SlideshareCracking the 'Career Pathing' Slideshare
Cracking the 'Career Pathing' SlideshareWorkforce Group
 
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)Adnet Communications
 
PHX May 2024 Corporate Presentation Final
PHX May 2024 Corporate Presentation FinalPHX May 2024 Corporate Presentation Final
PHX May 2024 Corporate Presentation FinalPanhandleOilandGas
 
Cannabis Legalization World Map: 2024 Updated
Cannabis Legalization World Map: 2024 UpdatedCannabis Legalization World Map: 2024 Updated
Cannabis Legalization World Map: 2024 UpdatedCannaBusinessPlans
 
Uneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration PresentationUneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration Presentationuneakwhite
 
How to Get Started in Social Media for Art League City
How to Get Started in Social Media for Art League CityHow to Get Started in Social Media for Art League City
How to Get Started in Social Media for Art League CityEric T. Tung
 

Último (20)

Organizational Transformation Lead with Culture
Organizational Transformation Lead with CultureOrganizational Transformation Lead with Culture
Organizational Transformation Lead with Culture
 
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai KuwaitThe Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
 
Mifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pills
Mifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pillsMifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pills
Mifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pills
 
CROSS CULTURAL NEGOTIATION BY PANMISEM NS
CROSS CULTURAL NEGOTIATION BY PANMISEM NSCROSS CULTURAL NEGOTIATION BY PANMISEM NS
CROSS CULTURAL NEGOTIATION BY PANMISEM NS
 
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabiunwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
 
BeMetals Investor Presentation_May 3, 2024.pdf
BeMetals Investor Presentation_May 3, 2024.pdfBeMetals Investor Presentation_May 3, 2024.pdf
BeMetals Investor Presentation_May 3, 2024.pdf
 
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in OmanMifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
 
Falcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investorsFalcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investors
 
Falcon Invoice Discounting: Tailored Financial Wings
Falcon Invoice Discounting: Tailored Financial WingsFalcon Invoice Discounting: Tailored Financial Wings
Falcon Invoice Discounting: Tailored Financial Wings
 
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAIGetting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
 
Katrina Personal Brand Project and portfolio 1
Katrina Personal Brand Project and portfolio 1Katrina Personal Brand Project and portfolio 1
Katrina Personal Brand Project and portfolio 1
 
Famous Olympic Siblings from the 21st Century
Famous Olympic Siblings from the 21st CenturyFamous Olympic Siblings from the 21st Century
Famous Olympic Siblings from the 21st Century
 
Cracking the 'Career Pathing' Slideshare
Cracking the 'Career Pathing' SlideshareCracking the 'Career Pathing' Slideshare
Cracking the 'Career Pathing' Slideshare
 
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
 
PHX May 2024 Corporate Presentation Final
PHX May 2024 Corporate Presentation FinalPHX May 2024 Corporate Presentation Final
PHX May 2024 Corporate Presentation Final
 
HomeRoots Pitch Deck | Investor Insights | April 2024
HomeRoots Pitch Deck | Investor Insights | April 2024HomeRoots Pitch Deck | Investor Insights | April 2024
HomeRoots Pitch Deck | Investor Insights | April 2024
 
!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...
!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...
!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...
 
Cannabis Legalization World Map: 2024 Updated
Cannabis Legalization World Map: 2024 UpdatedCannabis Legalization World Map: 2024 Updated
Cannabis Legalization World Map: 2024 Updated
 
Uneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration PresentationUneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration Presentation
 
How to Get Started in Social Media for Art League City
How to Get Started in Social Media for Art League CityHow to Get Started in Social Media for Art League City
How to Get Started in Social Media for Art League City
 

Getting to Approval Faster Through Technology Innovation

  • 1. December 14, 2017 Getting to Approval Faster through Technology Innovation
  • 2. © 2017 DIA, Inc. All rights reserved. Speakers Bio Page 2 Paul Slater Director, and Worldwide Industry Strategist, Pharmaceuticals Educational Background: • BSc (Hons) in Mathematics, King’s College London Career Overview: • Defines Microsoft’s strategy in life sciences, including regulatory compliance approach for the organization • Author of multiple position papers on hybrid, private and public cloud, platform modernization and IT Portfolio Management • Defined cloud and virtualization strategies across multiple corporations • @paul-slater
  • 3. © 2017 DIA, Inc. All rights reserved. Speakers Bio Page 3 Matt Neal Senior Director, Product Management – Regulatory & Clinical Solutions Educational Background: • MA Communications, Temple University Career Overview: • Defines PAREXEL product strategy in Regulatory for Life Sciences • 20+ years in Industry (Amgen & GSK) Regulatory & Safety Operations and electronic submissions pioneer • Lifelong learner with a focus on disruptive innovation and exponential technologies • Knowledge Management expert and author • Regulatory & Safety Operations Key Opinion Leader • Frequent Conference Speaker andAuthor • @matthewjneal
  • 4. © 2017 DIA, Inc. All rights reserved. Page 4 Meredith Sewell Executive Director, Allergan Global Regulatory Affairs Submissions Educational Background: • BA, English Literature, University of California, Irvine Career Overview: • Defines Allergan’s Global Ops Submission Strategy and Process • Drive Allergan’s partnership with Parexel to implement a cloud- based, vendor-hosted RIM and Publishing system • Reg Ops M&A integration and assimilation expert (20+ companies in 2 years) • Change management champion and optimizer of systems, resources and processes
  • 5. Describe factors that lead to inefficiencies in the drug discovery and development process Describe new technologies that will remove those inefficiencies Describe simplified powerful architectures designed to enhance specialized regulatory systems Recognize how organizations will be simplified as tools merge and become more intuitive © 2017 DIA, Inc. All rights reserved. Learning Objectives Page 5
  • 6. Introductions Roundtable Discussion Questions and answers © 2017 DIA, Inc. All rights reserved. Agenda Page 6
  • 7. © 2017 DIA, Inc. All rights reserved. Question 1 Page 7 Why is time from discovery to approval going up?
  • 8. Drug discovery is becoming slower and more expensive over time, despite improvements in technology (such as high throughput screening, biotechnology, combinatorial chemistry, and computational drug design) © 2017 DIA, Inc. All rights reserved. Eroom’s Law Page 8
  • 9. © 2017 DIA, Inc. All rights reserved. Where we are today Page 9
  • 10. Two years ago, Allergan became the conglomeration of 4 large companies: Allergan, Actavis, Watson, & Warner-Chilcott Each had an Investigator Payment system implemented and people to support them Narrowed down to iMedidata, and IMPACT iMedidata was not a “global” system but used widely – large amt of trials + large team to support IMPACT also needed to sustain global trials Sunshine Act requirements need to be met © 2017 DIA, Inc. All rights reserved. Allergan Investigator Payments - CTMS Page 10
  • 11. Technology and money are part of the problem • Technology, people and process are entwined for both Medidata and IMPACT • Expert users and number of trials • Expensive to integrate into one system • Contracts, data migration, new training • More expensive to retain two systems • IT resources • People + Process differences • No central/single source of information • Reporting and metrics are difficult • New technology could bridge the gaps and create effective opportunities for staff © 2017 DIA, Inc. All rights reserved. Allergan Investigator Payments (Cont’d) Page 11
  • 12. 1999 – 2010s – Process of adding hyperlinks was manual Proper template use helped; rendered styles to bookmarks, internal hyperlinks (cross- references) retained Touch up for bookmarks and hyperlinks were produced with pdf plugin tools Drawbacks: Time-consuming, people-driven, last minute work © 2017 DIA, Inc. All rights reserved. Regulatory Submission Publishing – Evolution of Bookmarking & Hyperlinking Page 12
  • 13. © 2017 DIA, Inc. All rights reserved. Question 2 Page 13 Can we reverse the trend?
  • 14. © 2017 DIA, Inc. All rights reserved. Where we are today Page 14
  • 15. © 2017 DIA, Inc. All rights reserved. What is needed Page 15 Applications Data Self-improving productsFlexible Architectures As Is To Be
  • 16. © 2017 DIA, Inc. All rights reserved. Question 3 Page 16 What do flexible architectures look like?
  • 17. © 2017 DIA, Inc. All rights reserved. POLL Page 17 Where are you in your cloud journey?  Fully on-premise (no cloud)  Dev/Test in the cloud  At least one Prod environment in the cloud  All environments in the cloud
  • 18. © 2017 DIA, Inc. All rights reserved. POLL Page 18 What is your biggest concern in adopting cloud computing?  Maintaining Security  Maintaining Data Integrity  Loss of Control  Disaster Recovery  Regulatory Compliance
  • 19. New view of Line of Business Architectures
  • 20. Data Architecture for Life Sciences
  • 21. Flexibility from Cloud Based Architectures Old World New World IT department has to plan upgrades
  • 22. Flexibility from Cloud Based Architectures Old World New World IT department has to plan upgrades No more upgrades, new features roll into product on an agreed schedule
  • 23. Flexibility from Cloud Based Architectures Old World New World IT department has to plan upgrades No more upgrades, new features roll into product on an agreed schedule High maintenance costs to maintain and integrate the platform
  • 24. Flexibility from Cloud Based Architectures Old World New World IT department has to plan upgrades No more upgrades, new features roll into product on an agreed schedule High maintenance costs to maintain and integrate the platform Maintenance built into the architecture. Simplified data integration through common data architecture
  • 25. Flexibility from Cloud Based Architectures Old World New World IT department has to plan upgrades No more upgrades, new features roll into product on an agreed schedule High maintenance costs to maintain and integrate the platform Maintenance built into the architecture. Simplified data integration through common data architecture “Feature drop” to meet version deadlines
  • 26. Flexibility from Cloud Based Architectures Old World New World IT department has to plan upgrades No more upgrades, new features roll into product on an agreed schedule High maintenance costs to maintain and integrate the platform Maintenance built into the architecture. Simplified data integration through common data architecture “Feature drop” to meet version deadlines Features developed according to customer demand, and rolled into product according to agreed schedule
  • 27. Flexibility from Cloud Based Architectures Old World New World IT department has to plan upgrades No more upgrades, new features roll into product on an agreed schedule High maintenance costs to maintain and integrate the platform Maintenance built into the architecture. Simplified data integration through common data architecture “Feature drop” to meet version deadlines Features developed according to customer demand, and rolled into product according to agreed schedule No benefit to adding new products and services
  • 28. Flexibility from Cloud Based Architectures Old World New World IT department has to plan upgrades No more upgrades, new features roll into product on an agreed schedule High maintenance costs to maintain and integrate the platform Maintenance built into the architecture. Simplified data integration through common data architecture “Feature drop” to meet version deadlines Features developed according to customer demand, and rolled into product according to agreed schedule No benefit to adding new products and services Data insights enhanced as new services are added
  • 29. Vivli – Data Sharing Platform 29
  • 30. CORE STRATEGY DIGITAL TRANSFORMATION – SOLUTIONCONVERGENCE